POCKiT diagnostics

POCKiT diagnostic explores new areas of Stroke affects 16,000,000 people each year. 33% of patients will die and 90% of survivors will have a disability for the rest of their lives. POCKiT diagnostics have discovered a novel biomarker panel that could increase stroke patient treatment from 4% to 40%. We are leading a £1,000,000 grant from the United Kingdom government to finish an extensive clinical study in order to achieve regulatory approval. Our goal is to achieve market approval in 2020. Visit the POCKiT diagnostics website:

https://www.pockitdx.co.uk/